| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 235-241 |
| Journal | Netherlands Journal of Medicine |
| Volume | 72 |
| Issue number | 4 |
| Publication status | Published - 2014 |
Cite this
Blommestein, H. M., Franken, M. G., Verelst, S. G. R., van Agthoven, M., Huijgens, P. C., & Uyl-de Groot, C. A. (2014). Access to expensive cancer drugs in Dutch daily practice: Should we be concerned? Netherlands Journal of Medicine, 72(4), 235-241.
@article{de5b78c3140d44db82a79e2bc13bc805,
title = "Access to expensive cancer drugs in Dutch daily practice: Should we be concerned?",
author = "H.M. Blommestein and M.G. Franken and S.G.R. Verelst and {van Agthoven}, M. and P.C. Huijgens and {Uyl-de Groot}, C.A.",
year = "2014",
language = "Undefined/Unknown",
volume = "72",
pages = "235--241",
journal = "Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "Van Zuiden Communications BV",
number = "4",
}
Blommestein, HM, Franken, MG, Verelst, SGR, van Agthoven, M, Huijgens, PC & Uyl-de Groot, CA 2014, 'Access to expensive cancer drugs in Dutch daily practice: Should we be concerned?' Netherlands Journal of Medicine, vol. 72, no. 4, pp. 235-241.
Access to expensive cancer drugs in Dutch daily practice: Should we be concerned? / Blommestein, H.M.; Franken, M.G.; Verelst, S.G.R.; van Agthoven, M.; Huijgens, P.C.; Uyl-de Groot, C.A.
In: Netherlands Journal of Medicine, Vol. 72, No. 4, 2014, p. 235-241.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Access to expensive cancer drugs in Dutch daily practice: Should we be concerned?
AU - Blommestein, H.M.
AU - Franken, M.G.
AU - Verelst, S.G.R.
AU - van Agthoven, M.
AU - Huijgens, P.C.
AU - Uyl-de Groot, C.A.
PY - 2014
Y1 - 2014
M3 - Article
VL - 72
SP - 235
EP - 241
JO - Netherlands Journal of Medicine
JF - Netherlands Journal of Medicine
SN - 0300-2977
IS - 4
ER -
Blommestein HM, Franken MG, Verelst SGR, van Agthoven M, Huijgens PC, Uyl-de Groot CA. Access to expensive cancer drugs in Dutch daily practice: Should we be concerned? Netherlands Journal of Medicine. 2014;72(4):235-241.